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Telmisartan, Cyclosporine, or 11RVIVIT attenuated stretch-induced alterations in Ito
density and protein expression, and prevented the stretch-induced abbreviation of
APD.
Conclusions: The activation of AT1-Calcineurin-NFAT pathway plays an important
role in regulating stretch-induced remodeling of Ito and preventing the stretch-induced
abbreviation of APD in cultured neonatal rat atrial myocytes.
GW25-e0792
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Su Hang, Wang Qian
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Objectives: The extent of neovascularization is closely linked to the inﬂammatory
reaction and inﬁltration of foam cells within atherosclerotic plaques. In this study, we
evaluated the feasibility of a radioactive-labeled aVb3 antagonist
99mTc-3PEG4-RGD
for vulnerable plaque imaging in vivo by SPECT/CT.
Methods: 15 male New Zealand white rabbits were randomly divided into normal diet
group (group A, n¼5), vulnerable plaque group (group B, n¼5) and stable plaque
group (group C, n¼5). The animals were treated with the operation of sham separating
femoral artery (group A, C) or abdominal aorta balloon injury (group B) after fed for 2
weeks. 99mTc-3PEG4-RGD was injected at key time points of plaque formation (4wk
end, 8wk end, 12wk end), images were obtained with SPECT/CT at 0.5 h, 1 h and 2 h
after injection. Each group executed one rabbit at the end of 4wk, 8wk, and the rest
were executed at the end of 12wk. Vitro SPECT imaging, pathology and immuno-
histochemistry analysis was performed to validate the presence of plaque and micro-
vessels.
Results: In vivo and vitro imaging study, at the end of 4wk, there was no signiﬁcant
uptake in abdominal aorta in all three groups; at the end of 8wk and 12wk, group B, C
both had certain radioactive uptake. The uptake in group B was much higher
compared with group A, C (12wk end, 0.5h after injection, the T/NT values of A, B, C
group were 1.270.07,1.910.11 and 1.620.06); CD31 immunohistochemical
staining conﬁrmed that at the end of 8wk and 12wk the number of micro-vessels in
group B was signiﬁcantly higher than group C; Histopathology results showed that at
the end of 12wk group B, animals’ AHA atherosclerotic type was type III and IV, and
group C was typeII. All the rabbits in group A had no exist of vulnerable plaque and
micro-vessels in abdominal aorta.
Conclusions: The uptake of molecular probe 99mTc-3PEG4-RGD is closely associ-
ated with the number of micro-vessels and the severity of vulnerable plaque.
99mTc-RGD has a certain value for noninvasively evaluating the stability of arterial
plaque.
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Metformin attenuates Angiotensin II induced cardiac ﬁbrosis and cardiac
connective tissue growth factor (CTGF) expression through AMP-activated
protein kinase activation
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Objectives: In diabetic patients, metformin appears to provide cardiovascular pro-
tection that cannot be attributed only to its antihyperglycemic effects. Metformin is
also known as the AMP-activated protein kinase (AMPK) activator. Our previous
study suggested that metformin inhibits cardiac ﬁbrosis in a mouse heart failure model
of pressure overload. Connective tissue growth factor (CTGF) is one of key factors in
cardiac ﬁbrosis and is usually induced by Angiotensin II (AngII) in the pressure
overload mouse models. Metformin might play its cardioprotective role through in-
hibition of cardiac ﬁbrosis and CTGF production. This study investigated the effect of
metformin on CTGF production induced by AngII and the underlying mechanisms.
Methods: C57/BL6 wild-type and AMPKa2 knockout were used. (3mg/kg*day) was
infused subcutaneously into mice for 7 days. Adult mouse cardiac ﬁbroblasts were
isolated and treated with AngII and/or metformin. Realtime PCR, western blot were
performed for the further experiments.
Results: In C57/BL6 mice, metformin inhibits AngII-induced cardiac ﬁbrosis (AngII
vs. AngII+Metformin: 12.601.97% vs. 7.261.30% ﬁbrosis area percentage,
P<0.05). In cardiac ﬁbroblasts, metformin inhibits CTGF expression induced by
AngII (fold of control mRNA level, AngII vs. AngII+Metformin: 1.3760.049
vs.0.9970.067, P<0.05). In vivo, AMPKa2 deﬁciency further increases AngII-
induced cardiac ﬁbrosis (AngII + wild type vs. AngII+ AMPKa2 knockout:
2.160.5% vs. 4.911.05% ﬁbrosis area percentage, P<0.05) and CTGF expression
(fold of control mRNA level, AngII + wild type vs. AngII+ AMPKa2 knockout:
2.5510.212 vs. 6.2451.094, P<0.05). Using bioinformatics method, we found that
there are putative HNF4a binding sites in the promoter region of CTGF. A 2-fold
increased expression of CTGF was found in cardiac ﬁbroblasts infected with HNF4a
adenovirus. In cardiac ﬁbroblasts, metformin inhibits HNF4a protein level induced by
AngII (fold of control, AngII vs AngII+Metformin: 4.1710.818 vs 2.5470.903,
P<0.05). In vivo, AMPKa2 deﬁciency further increases AngII-induced HNF4a pro-
tein level (fold of control, wild type vs. AMPKa2 knockout: 2.0640.241 vs.
4.1980.142, P<0.05).
Conclusions: Metformin inhibits AngII induced cardiac ﬁbrosis and CTGF expres-
sion through AMPK activation. The underlying mechanism is that AMPK activation
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Objectives: This study is to demonstrate that Ig molecules can be expressed in
myocardial tissue and their classes and localization. Meanwhile, observe the expres-
sion and localization of Ig in mice ﬁbrotic myocardial tissue.
Methods: Wild type mice and B cell deﬁcient mice were used as objects. First,
extracorporeal heart perfusion method was used to exclude the contamination of
blood. Then we detected the expression and localization of IgM, IgE by Western Blot,
RT-PCR, Immunohistochemistry and Immunoﬂuorescence method. We also detected
the expression of IgM, IgE in primary cultured cardiomyocyte and HL-1 cells by RT-
PCR. Moreover, we analyzed the characteristics of Ig variable region sequences and
observed their localization in cardiomyocyte. C57BL/6 mice were divided into two
groups: the sham group and the test group. The test group was injected with angio-
tensin II while the sham group was injected with saline for 14 days through a micro
pump post in the back hypodermal. Then the mice were killed, Western Blot and
immunohistochemistry staining were taken to detect Ig.
Results: IgM, IgE, IgG, IgK can be expressed in the heart tissue of both wild type and
B cell deﬁcient mice and localized mainly on the cross striations, however, IgM can
also be observed on the cell membrane and intercalated discs. Furthermore, we
detected Ig expression in primary cultured cardiomyocyte and HL-1 cells. We
observed that different cell linage (cardiomyocyte and cardiac ﬁbroblast) showed quite
different rearrangement patterns, but the same cell linage showed the same pattern. We
also observed that the variable region sequences of cardiomyocyte-derived IgM and
Igk showed obvious tendency and highly homology. IgM localized mainly on the cell
membrane especially on the cell junction. IgE and Igk showed network-like structure
in the cytoplasm.
Comparing the ﬁbrosis group with the sham group, Ig expression were up-regulated
in myocardial cells. In the ﬁbrosis area, the staining seems to disappear.
Conclusions: This is the ﬁrst time to demonstrate that mice cardiomyocyte can pro-
duce Ig and these cardiomyocyte-derived Ig showed quite different functions
comparing with Ig produced by B cells, which demonstrate that these cardiomyocyte-
derived Ig may participate in the regulation of myocyte contraction and myocardial
ﬁbrosis.
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The role and mechanism of RAS-MAPK/ERK in right heart dysfunction
associated with pulmonary hypertension
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Objectives: To observe in protein expression of AT1R, TGF-b1and ERK1/2 in pul-
monary hypertension related right ventricle remodeling.
Methods: 24 male SD rats were randomly divided into: Group 1 (control group),
Group 2 (PAH group), Group 3 (Olmesartan Control) and Group 4 (Olmesartan PAH).
After 6 weeks, all survival rats were detected by echocardiography and right cathe-
terization to observe the RVWAd and mPAP, RVSP. Weighted the RV and (LV +SP),
to ﬁgure out the RVHI. Right ventricles tissue was staining with HE and TEM. The
collagen type I were detected by collagen volume fraction (CVF). Plasma concen-
trations of AngII was determined by radioimmunoassay. Expressions of AT1R, TGF-
b1 and ERK1/2 protein of right ventricles tissue were determined by western blot.
Right ventricular cardiac ﬁbroblasts (RVCFs) obtained from neonatal rats were
cultured and divided into: PBS control group (group 1), AngII group (group 2), Ang-
(1-7) group (group 3), U0126 group (group 4), Losartan group (group 5). RVCFs
multiplication was detected by MTT coloricmetric assay. The expression levels of
TGF-b1 were measured by Immunohistochemistry. The expression levels of Collagen
type I was measured by western blotting.
Results: After 6 weeks, no mortality occurs. Compared with the group 1, RVAWd,
mPAP, RVSP and RVHI signiﬁcantly increased in group2 (P<0.01) and Compared
with the group 2, RVAWd signiﬁcantly decreased in group4 (P<0.01). In group 2, the
microstructure of right ventricles show cardiac myocyte hypertrophy, interstitial
ﬁbrosis lined up in disorder, mitochondria swell, and the Z lines broken. These
changes improved to some extent in group 4. CVF in group 2 was signiﬁcant higher
than that in group 1 (P<0.05), and group 4 was signiﬁcant lower than that in group 2
(P<0.05). Plasma concentrations of AngII markedly increased in group 2 (P<0.05),
and there was no signiﬁcant difference between group 4 and group 2 (P>0.05). AT1R,
TGF-b1 and ERK1/2 protein expression markedly increased (P<0.01) in group 2.
Compared with group 2, AT1R, TGF-b1 and ERK1/2 protein expression in group 4
markedly decreased (P<0.01). The proliferative capacity of group 2 was signiﬁcantly
increased as compared with group 1, while the proliferative capacity of group 3-5 was
signiﬁcantly decreased as compared with group 2, respectively. The levels of TGF-b1
and collagen type I in group 2 were signiﬁcantly increased as compared with group 1.
Compared with group 2, the levels of TGF-b1 and collagen type I markedly decreased
in group 3-5, respectively.
Conclusions: In MCT-induced pulmonary hypertension related RV remodeling rats,
AT1R, TGF-b1 and ERK1/2 protein expression of right ventricles were up-regulated,
and Plasma concentrations of AngII markedly increased. Olmesartan inhibited theasic and Translational Medicine C33
